A statement for extensive primary cytoreductive surgery in advanced ovarian cancer

This publication has 18 references indexed in Scilit:

• The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients
  British Journal of Cancer, 2007
• Multi-Institutional Reciprocal Validation Study of Computed Tomography Predictors of Suboptimal Primary Cytoreduction in Patients With Advanced Ovarian Cancer
  Journal of Clinical Oncology, 2007
• Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
  Gynecologic Oncology, 2007
• Surgery for ovarian cancer: how to improve survival
  The Lancet, 2006
• Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer
  Gynecologic Oncology, 2005
• Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial
  Journal of Clinical Oncology, 2005
• Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial
  JNCI Journal of the National Cancer Institute, 2005
• Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study
  Gynecologic Oncology, 2005
• Relationship Between Time Interval From Primary Surgery to the Start of Taxane- Plus Platinum-Based Chemotherapy and Clinical Outcome of Patients With Advanced Epithelial Ovarian Cancer: Results of a Multicenter Retrospective Italian Study
  Journal of Clinical Oncology, 2005
• Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach
  Gynecologic Oncology, 2004